Positive ELISA-2 Antibody Result
A positive ELISA antibody test requires immediate confirmation with a supplemental test—either PCR/nucleic acid testing for active infection or a confirmatory antibody assay (such as Western blot or recombinant immunoblot assay)—because false positives are common, particularly in low-prevalence settings.
Understanding the Result
A positive ELISA test indicates one of three possibilities:
- Active infection (acute or chronic)
- Past resolved infection
- False positive result
The ELISA alone cannot distinguish between these scenarios 1. Third-generation ELISA tests have 97% sensitivity but still produce false positives at rates that can exceed true positives in low-prevalence populations 1.
Immediate Next Steps
For Suspected Hepatitis C (Most Relevant Context)
Step 1: Order HCV RNA by PCR immediately
- This is the critical confirmatory test 1
- PCR detects active viral replication with sensitivity of 500-1000 viral equivalents/mL 1
- Results interpretation:
- PCR positive = Current active infection requiring specialist referral
- PCR negative = Proceed to Step 2
Step 2: If PCR is negative, obtain recombinant immunoblot assay (RIBA)
- Confirms whether the ELISA represents true antibody or false positive 1
- RIBA interpretation:
- Positive (reactivity to ≥2 antigens) = Past resolved infection
- Indeterminate (reactivity to 1 antigen) = 58% still have detectable HCV RNA; repeat PCR 1
- Negative = False positive ELISA
For HIV Testing Context
Step 1: Confirm with Western blot or immunofluorescence assay (IFA)
Step 2: If Western blot is positive, obtain HIV RNA viral load
- Confirms active infection
- Establishes baseline for treatment monitoring
Critical Clinical Pitfalls
False positives are particularly common in:
- Low-prevalence populations where false positives may outnumber true positives 1
- Pregnancy (significantly higher false positive rate, p=0.033) 4
- Autoimmune diseases (rheumatoid arthritis, SLE) 5
- Syphilis (85% of TPHA-positive sera show false-positive ELISA for Borrelia) 5
- Samples with quantitative results near the cutoff value (fifth percentile) 6
Never diagnose infection based on ELISA alone—this is the single most important principle 1, 2.
Special Populations
Patients with Chronic Liver Disease
- A positive ELISA is likely sufficient for diagnosis 1
- Still recommend confirmatory PCR rather than additional antibody testing 1
- Proceed directly to specialist referral
Immunosuppressed Patients
- May be antibody-negative despite active infection 1
- Qualitative PCR is mandatory even with negative ELISA if clinical suspicion exists 1
Pregnant Women
- Higher false positive rates documented 4
- Molecular confirmation absolutely required before initiating any treatment 4
- Do not start antiretroviral therapy based on ELISA alone
Management Algorithm
All patients with confirmed positive results require:
- Referral to specialist service (hepatology for HCV, infectious disease for HIV) 1
- Baseline liver function tests (though these correlate poorly with disease severity) 1
- Clinical assessment for disease stage
- Evaluation for treatment candidacy
Timeline considerations:
- Antibodies develop 2-6 months post-exposure 7
- Viral RNA detectable 1-3 weeks post-exposure 7
- Negative antibody test does not exclude infection within past 6 months 2, 3
The key principle: treat ELISA as a screening test only, never as a diagnostic test. The clinical and public health consequences of misdiagnosis—whether false positive or false negative—are too significant to bypass confirmatory testing 1, 2.